Search

Your search keyword '"Romano, Gabriele"' showing total 287 results

Search Constraints

Start Over You searched for: Author "Romano, Gabriele" Remove constraint Author: "Romano, Gabriele"
287 results on '"Romano, Gabriele"'

Search Results

1. Investigating the shortcomings of the Flow Convergence Method for quantification of Mitral Regurgitation in a pulsatile in-vitro environment and with Computational Fluid Dynamics

2. On-demand mitral valve morphometrics during surgical repair

3. Improving Output Visualization of an Algorithm for the Automated Detection of the Perceived Origin of Movement

6. mvHOTA: A multi-view higher order tracking accuracy metric to measure spatial and temporal associations in multi-point detection

7. Comparison of Depth Estimation Setups from Stereo Endoscopy and Optical Tracking for Point Measurements

8. Point detection through multi-instance deep heatmap regression for sutures in endoscopy

9. Mutually improved endoscopic image synthesis and landmark detection in unpaired image-to-image translation

11. Heatmap-based 2D Landmark Detection with a Varying Number of Landmarks

15. Multi-modal molecular programs regulate melanoma cell state

18. An ex-vivo and in-vitro dynamic simulator for surgical and transcatheter mitral valve interventions

24. APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe−/− atherosclerotic mice

25. Surgical training of minimally invasive mitral valve repair on a patient-specific simulator improves surgical skills.

26. Supplementary Figures S1-S5 from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma

27. Data from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma

28. Supplementary Tables from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma

29. Supplementary Figures from A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling

30. Supplementary Tables from A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling

31. Data from A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling

32. Supplementary Figure Legends from A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling

34. Supplementary Figure 5 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

35. Supplementary Figure 4 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

36. Supplementary Table 1 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

37. Supplementary Data from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

38. Supplementary Table 2 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

39. Supplementary Figure 1 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

40. Supplementary Figure 2 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

41. Supplementary Table 3 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

42. Supplementary Figure 6 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

43. Supplementary Figure 3 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

45. Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma

46. mvHOTA: A multi-view higher order tracking accuracy metric to measure temporal and spatial associations in multi-point tracking.

48. Tumor Microenvironment and Immune Escape in the Time Course of Glioblastoma.

49. The GermAn Laser Lead Extraction RegistrY: GALLERY

50. Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma

Catalog

Books, media, physical & digital resources